Molecular biology methods for blood cell antigen genotyping in reference laboratories
Open Access
- 31 December 2019
- journal article
- Published by VM Media Group sp. z o.o in Journal of Transfusion Medicine
- Vol. 12 (4) , 199-205
Abstract
The aim of the study is to present current applications of molecular biology methods in immunohematology as well as the status of their implementation in the Polish Blood Transfusion Service. Molecular biology methods are used for: analysis of molecular background of blood cell antigens in individuals with discrepant results of serological tests, identification of RhD antigen with weak expression undetectable by serological methods in blood donors, identification of weak D type antigen in recipients unsusceptible to alloimmunization. These methods are also used for noninvasive study of fetal genes in plasma samples of immunized pregnant women with serological incompatibilities and in RhD negative pregnant women for qualification to antenatal prophylactic administration of anti-D immunoglobulin. Molecular biology is also an important tool for diagnostics of patients with antibodies to high-frequency blood group antigens (HFA) or for patients immunized with HPA and HNA antigens and for identification of “antigen-negative” blood donors for such patients. In Poland, all these tests are available and in use. The aim of the study is to present current applications of molecular biology methods in immunohematology as well as the status of their implementation in the Polish Blood Transfusion Service. Molecular biology methods are used for: analysis of molecular background of blood cell antigens in individuals with discrepant results of serological tests, identification of RhD antigen with weak expression undetectable by serological methods in blood donors, identification of weak D type antigen in recipients unsusceptible to alloimmunization. These methods are also used for noninvasive study of fetal genes in plasma samples of immunized pregnant women with serological incompatibilities and in RhD negative pregnant women for qualification to antenatal prophylactic administration of anti-D immunoglobulin. Molecular biology is also an important tool for diagnostics of patients with antibodies to high-frequency blood group antigens (HFA) or for patients immunized with HPA and HNA antigens and for identification of “antigen-negative” blood donors for such patients. In Poland, all these tests are available and in use.Keywords
This publication has 39 references indexed in Scilit:
- Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and PreventionArchivum Immunologiae et Therapiae Experimentalis, 2015
- Charakterystyka molekularna i serologiczna słabych odmian antygenu D u dawców RCKiK w BiałymstokuActa Haematologica Polonica, 2015
- Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancyPrenatal Diagnosis, 2015
- Routine noninvasive prenatal screening for fetal RHD in plasma of RhD‐negative pregnant women—2 years of screening experience from DenmarkPrenatal Diagnosis, 2014
- Implementation of a mandatory donor RHD screening in SwitzerlandTransfusion and Apheresis Science, 2014
- Alloprzeciwciała do antygenów występujących z wysoką częstością wykryte w Polsce w latach 2000–2012Acta Haematologica Polonica, 2013
- DNA-based methods in the immunohematology reference laboratoryTransfusion and Apheresis Science, 2011
- Preliminary results of fetal Rhc examination in plasma of pregnant women with anti‐cPrenatal Diagnosis, 2008
- The frequency of human platelet antigen (HPA) genotypes in the Polish populationTransfusion Medicine, 1998
- Cloning and characterization of DNA complementary to human UDP-GalNAc: Fuc alpha 1----2Gal alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA.Journal of Biological Chemistry, 1990